Use of placental stem cells in treatment of acute kidney injury
AssigneeCelularity Inc.
InventorsSteven A. Fischkoff, Hong-Jung Chen
Life of this patent
Estimating the term…
Abstract
Provided herein are methods of using human placental stem cells in the treatment of subjects having acute kidney injury (AKI).
Claims11
A method of treating acute kidney injury (AKI) in a subject having AKI comprising administering to the subject a therapeutically effective amount of placental stem cells, wherein the therapeutically effective amount is an amount sufficient to cause a detectable improvement in one or more symptoms or complications of AKI, or a reduction in the progression of one or more symptoms or complications of AKI, in the subject, wherein said AKI is the result of direct trauma to one or more of the kidneys of the subject.
A method of preventing one or more symptoms or complications associated with acute kidney injury (AKI) in a subject having AKI comprising administering to the subject a therapeutically effective amount of placental stem cells, wherein the therapeutically effective amount is an amount sufficient to prevent the onset of one or more symptoms or complications of AKI in the subject, wherein said AKI is the result of direct trauma to one or more of the kidneys of the subject.
Dependencies are inferred from the claim text.